©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 110981
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.110981
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.110981
Table 1 Gastrin and Helicobacter pylori quantitative assays, mean ± SD
| n | Gastrin level (pmol/L) | Helicobacter pylori quantitative assays (disintegrations per minute) | |
| Gastric cancer group | 226 | 26.02 ± 7.93 | 275.42 ± 62.36 |
| Control group | 100 | 16.02 ± 4.10 | 163.36 ± 59.63 |
| t | 18.09 | 12.99 | |
| P value | < 0.001 | < 0.001 |
- Citation: Huang JW, Lin C, Lu CJ, Wang HS, Zou DD. Serum gastrin and Helicobacter pylori infection correlate with tumor aggressiveness and prognosis in gastric cancer. World J Gastrointest Oncol 2025; 17(9): 110981
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/110981.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.110981